Chul‐Min Ahn

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome

Byeong‐Keuk Kim, Sung‐Jin Hong, Yun‐Hyeong Cho et al. · JAMA · 2020 · 524 citations · Full text

Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial

Byeong‐Keuk Kim, Sung‐Jin Hong, Yong‐Joon Lee et al. · The Lancet · 2022 · 285 citations · Full text

Effect of Intravascular Ultrasound–Guided Drug-Eluting Stent Implantation

Sung‐Jin Hong, Gary S. Mintz, Chul‐Min Ahn et al. · JACC: Cardiovascular Interventions · 2020 · 266 citations · Full text

Drug-eluting Stent Implantation, Engineering, Endovascular Technique +6